Diethylpropion
- Generic Name
- Diethylpropion
- Brand Names
- Tepanil
- Drug Type
- Small Molecule
- Chemical Formula
- C13H19NO
- CAS Number
- 90-84-6
- Unique Ingredient Identifier
- Q94YYU22B8
- Background
A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)
- Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
- Associated Conditions
- Exogenous Obesity
Anti-obesity Pharmacotherapy and Inflammation
- Conditions
- Obesity
- Interventions
- Drug: Phentermine-Topiramate combinationDrug: Naltrexone/Bupropion
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2025-01-10
- Target Recruit Count
- 30
- Registration Number
- NCT05756764
- Locations
- 🇺🇸
LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO, New Orleans, Louisiana, United States
🇺🇸Ochsner Health System - Biospecimen, New Orleans, Louisiana, United States
LOSS- Louisiana Obese Subjects Study
- Conditions
- Obesity
- Interventions
- Behavioral: group sessionsOther: Control ConditionBehavioral: Low Calorie Diet, Health OneOther: Intensive Medical Combination Therapy for Obesity
- First Posted Date
- 2005-06-21
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- Pennington Biomedical Research Center
- Target Recruit Count
- 390
- Registration Number
- NCT00115063
- Locations
- 🇺🇸
Pennington Management of Clinical Trials, Baton Rouge, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.